27.2 C
Vientiane
Saturday, August 30, 2025
spot_img
Home Blog Page 96

State Grid Gansu Linxia Power Supply Company: Answering the “ecological protection” question in power grid construction

LINXIA, China, Aug. 20, 2025 /PRNewswire/ — On the 14th of August, employees of State Grid Gansu Linxia Power Supply Company were conducting peak summer and flood prevention patrols along the newly put into operation of the 110 kV Zhebei Second Line in the northern part of Linxia County. They saw birds flying into their “nests”. This scene made him unable to help but share his joy with his colleagues: “For birds, this is a safe haven, and the risk of electric shock is almost zero; For the power grid, this is a reliable defense line, and bird damage faults have decreased significantly, making agricultural irrigation and enterprise production electricity more stable.”

Linxia Prefecture is located in the transitional zone between the Qinghai-Xizang Plateau and the Loess Plateau. It is an important water conservation area and ecological functional area in the upper reaches of the Yellow River, with a significant ecological position. With the increasing biodiversity, more and more birds are living here.

“There is a natural conflict between bird habitats and power grid towers. Bird droppings, nesting materials such as twigs and wires, if they fall on the lines, may cause line failures, which also threaten the safety of birds,” said Mu Zhengrong. “In the past, we installed various bird repellents such as bird spikes, but the birds still liked to nest here, and no matter how we tried to drive them away, line failures caused by birds still occurred from time to time.”

In recent years, State Grid Linxia Power Supply Company has established and practiced the concept of lucid waters and lush mountains are invaluable assets, firmly promoting the harmonious development of the power grid and natural ecology. In the initial stage of the design of the Linxia Beiyuan (Qiaosi) 110 kV transmission and transformation project, we actively coordinated with the design unit, integrated ecological environment protection into the construction of the power grid, and designed a “nest” at the top of the power grid tower according to the living habits of birds “choose to live high”. Transforming the traditional bird prevention and bird drive in the construction of the power grid into attracting and attracting birds. The core concept of “digital intelligence and green low-carbon” is integrated throughout the entire construction process.

Blocking is not as good as dredging. This ecological and friendly grid construction model, with “Anju Nest” as the carrier, not only reflects respect for natural beings but also demonstrates the ecological responsibility of the enterprise.

Today, walking in the Linxia Beiyuan area, the green power grid continues to extend in the fields, and one after another “nests of peace” have become habitats for birds. State Grid personnel are protecting the green mountains and clear waters as if they were their own eyes, and nurturing the ecological environment as if it were their own life, striving to answer the “ecological protection” question in power grid construction.

SW China’s Xizang makes remarkable economic, social achievements over 60 years

BEIJING, Aug. 20, 2025 /PRNewswire/ — A report from People’s Daily: This year marks the 60th anniversary of the establishment of southwest China’s Xizang autonomous region. Wang Junzheng, secretary of the Communist Party of China (CPC) Xizang Autonomous Regional Committee, and Gama Cedain, deputy secretary of the CPC Xizang Autonomous Regional Committee and chairman of the People’s Government of the region, introduced the region’s remarkable economic and social development achievements at a press conference held by the State Council Information Office recently.

In 2024, the region’s gross domestic product (GDP) reached 276.5 billion yuan ($38.52 billion), 155 times that of 1965 in constant prices. While it took the region 50 years to achieve its first 100 billion yuan in GDP, the second 100 billion yuan milestone was reached in just six years, Wang said.

Since 2021, sustained efforts have further expanded Xizang’s economy while improving the quality and efficiency of growth. Modern industries, including clean energy, cultural tourism and plateau light industry, are laying the foundation for a modern industrial system. The region’s key economic indicators have ranked among the highest growth rates in the country for several consecutive years, with its regional GDP projected to surpass 300 billion yuan this year, reaching the third 100 billion yuan milestone.

Xizang’s infrastructure has also significantly improved. By the end of 2024, the total operational road length and the railway length in the region had reached 124,900 kilometers and 1,359 kilometers, respectively, and its domestic and international air routes reached 183. Four major power grids had been put into use, with the main grid now covering all counties, districts, and cities in the region.

These developments have substantially resolved historical infrastructure constraints, providing significant momentum for high-quality regional development, Wang noted.

Xizang boasts a long history and a splendid culture, alongside unique natural landscapes and rich cultural resources. It is an important center for preserving the distinctive culture of the Chinese nation and a major global tourism destination, enjoying exceptional advantages in developing the cultural tourism industry, which has experienced robust growth in recent years.

In 2024, the total output value of Xizang’s cultural industry increased by 23.8 percent, according to Gama Cedain. The region received 63.89 million domestic and international visitors, marking a 15.8 percent year-on-year increase. Notably, the number of inbound tourists skyrocketed by 188.2 percent. In the first half of this year, Xizang welcomed over 32.18 million visitors, representing an 11.7 percent increase year on year.

Meanwhile, living standards have improved dramatically. In 2024, the per capita disposable income of urban residents in Xizang reached 55,444 yuan, 121 times that of 1965. The per capita disposable income of rural residents hit 21,578 yuan, 199 times that of 1965.

Xizang has achieved a comprehensive victory over poverty and eliminated absolute poverty. Education has been made a top priority, with the region leading the nation in providing a 15-year publicly funded education program from kindergarten to senior high school.

A comprehensive public healthcare system offers free health checkups for all farmers and herders, contributing to a regional life expectancy of 72.5 years. Accelerated urbanization has transformed settlements into modern towns.

Over the 60 years since the establishment of the autonomous region – particularly in the past five years – Xizang has vigorously advanced various livelihood projects and programs. People of all ethnic groups have witnessed transformative changes in their daily lives, such as shifting from carrying water in buckets to enjoying running water, from oil lamps to electric lighting, from dirt roads to paved highways, and from yurts to modern housing, according to Gama Cedain.

During the 14th Five-Year Plan period (2021-2025), the state and the autonomous region plan to allocate 24.65 billion yuan to support 28 categories of regional social development projects. As of now, 23.678 billion yuan has already been invested in these projects.

A wide range of livelihood initiatives have been effectively implemented, including centralized heating and oxygen supply in high-altitude areas, the resolution of seasonal water shortages in agricultural and pastoral zones, enhanced reliability of power supply, and comprehensive coverage of fiber-optic broadband and 4G networks.

Located on the Qinghai-Xizang Plateau, known as the “roof of the world” and “Asia’s water tower,” Xizang serves as a vital ecological security barrier for China. How can the region safeguard the plateau’s unique ecological environment while preserving its biodiversity and natural wonders?

Xizang has adopted the strictest ecological protection system in accordance with law. It has firmly upheld a policy of rejecting the approval or introduction of projects and enterprises that are high in energy consumption and emissions but low in efficiency, strictly prohibiting any pollution-prone projects on the plateau. The region has actively promoted national park construction and advanced the afforestation project in the northern and southern mountains of Lhasa, the regional capital. Ecological conservation red line zones have been drawn for more than 50 percent of the region’s land area, with protected areas of all types and levels now accounting for 37.95 percent of its land area.

Low-carbon development has also been vigorously pursued. In 2024, over 99 percent of electricity in Xizang was generated from clean energy, the highest of all regions in China. Non-fossil energy consumption in the region exceeded 55 percent of total energy use, placing it among the top in the country in green energy.

Today, Xizang’s natural environment is among the best preserved in the world. “We will firmly uphold the principle that ‘lucid waters and lush mountains are invaluable assets and so are ice and snow,’ persistently serving as guardians to make the Qinghai-Xizang Plateau an ecological treasure shared by mankind and contributing more to building a shared future for all life on Earth,” Wang said.

 

First IPO Under GIFT City’s IFSC Regime – DRHP Filed; Executive Education Platform Leads the Charge

XED, a global executive education platform partnering with Ivy League institutions, moves toward an international listing under GIFT IFSC regulations, in a process open to eligible non-resident investors.

MUMBAI, India, Aug. 20, 2025 /PRNewswire/ — XED, a global executive education platform delivering premium leadership programs in collaboration with Ivy League and other world-class global academic institutions, has filed its Draft Red Herring Prospectus (DRHP), making it the first company progressing toward an IPO under GIFT City’s IFSC regime. The proposed listing will be on NSE IFSC, enabling global investors to participate under India’s evolving international capital markets framework.

Over the last decade, XED has built a portfolio of strategic partnerships with top global institutions, offering immersive leadership programs tailored for CXOs and business heads worldwide. Operating across India, the GCC, Southeast Asia, LATAM, and the US, XED serves senior leaders through hybrid and in-person formats focused on transformation, AI leadership, financial stewardship, and innovation.

With GIFT City rapidly positioning itself as a new frontier for international listings, XED’s DRHP filing reflects strategic intent to access global capital while remaining aligned with Indian oversight. “This IPO isn’t just a capital event – it’s a strategic inflection point for the entire executive education space. We’re building a category where deep learning, global faculty access, individual learning goals and enterprise context intersect. The DRHP filing is just the beginning,” said John Kallelil, Managing Director, XED Executive Development Limited.

“Our forthcoming listing underscores XED’s commitment to growth and innovation,” added Piyush Agrawal, CFO, XED, emphasizing that the listing will help the firm unlock new foreign capital avenues. Abhishek Kaushik, CEO of Global Horizons Capital Advisors, noted that XED’s decision demonstrates confidence in GIFT IFSC as a credible international financial hub.

The company plans to use the listing to further expand university partnerships, develop new programs for high-growth sectors, and scale delivery internationally. Offerings such as the Oxford General Management Program, Cornell Chief AI Officer Program and other boardroom-level interventions illustrate the firm’s stronghold in CXO education.

The proposed issue is open only to eligible non-resident Indian and foreign nationals, as per Indian Foreign Exchange Management Act (FEMA), 1999.he proposed issuance is open only to eligible non-resident investors, as per GIFT IFSC regulations.

Sisram Medical Reports First-Half 2025 Results: Injectables Surge as AI-Powered EBD Strengthens Segment Positioning

HONG KONG, Aug. 20, 2025 /PRNewswire/ — Sisram Medical Ltd (the “Company” or “Sisram”, 1696.HK; referred to collectively with its subsidiaries as the “Group”), a global consumer wellness group, featuring a distinguished synergistic ecosystem of business building blocks and consumer-focused approaches including Energy-Based Devices (EBD), and Injectables, alongside other complementary offerings, today announced its unaudited consolidated interim results for the six months ended June 30, 2025 (the “Reporting Period“).

FINANCIAL HIGHLIGHTS

  • Revenue was US$165.5 million, representing a decrease of 1.9% YoY
  • Revenue of Injectables line achieved US$14.4 million, representing a significant increase of 218.1% YoY
  • Revenue in the international market[1] was US$108.9 million, up 7.1% YoY. In APAC, revenue achieved a 17.6% increase YoY
  • Gross margin decreased from 62.4% to 60.0%, mainly due to a shift toward higher-cost core-professionals and sophisticated products with premium materials, along with lower North America revenue share
  • Adjusted net profit was US$12.0 million, down 28.1% YoY

Advancing EBD Market Potential with AI powered Innovations for an Intelligent, Integrated Approach to Aesthetic Care 
During the Reporting Period, Sisram reinforced its leadership in non-invasive body contouring with peer-reviewed validation of the Alma Accent Prime platform in the Nature Scientific Reports, creating new commercial opportunities globally. Alma Harmony also exceeded expectations, further strengthening the Company’s position in advanced aesthetic solutions.

Expanding beyond energy-based technologies, Sisram introduced innovations that build an intelligent, integrated infrastructure across the patient journey. In North America, Universkin by Alma marked a milestone in AI-assisted skincare, gaining rapid adoption and positive feedback. The Alma IQ intelligent skin analysis platform was introduced globally to enhanced diagnostic precision, treatment planning, and patient engagement.

By harnessing AI, Sisram is moving from standalone treatments to comprehensive solutions, unlocking new potential through combined therapies and advancing its strategic leadership in medical aesthetics.

Expanding Dermal Injectables Global Footprint with Successful Market Entry and Scaling in Key Markets
Sisram’s injectables business continued to strengthen as the Company’s second growth engine, delivering robust growth of 218.1% during the Reporting Period. This marks a strategic evolution from technology development to global commercialization, signaling the entry of this line of business into a growth harvest phase.

The Company accelerated penetration of Profhilo, its next-generation hyaluronic acid–based bioremodeling product, in Thailand, establishing it as a category benchmark and driving strong sales and profitability. Preparations progressed for the mainland China launch of DAXXIFY, a long-lasting botulinum toxin type A product which is expected to take place in the coming months.

Sisram also enhanced commercialization of the Revanesse filler series, building specialized teams in the UK, DACH, Australia and New Zealand with the aim of strengthening regional operations. In addition, the Company continued to advance the commercialization in strategic regions of its partner Hallura and it first-of-its-kind hyaluronic acid biostimulator combination.

Leveraging its commercial infrastructure and expanding penetration in key markets, Sisram is laying a solid foundation for scalable growth in dermal injectables, further reinforcing its ecosystem advantage in global medical aesthetics.

Accelerating High-Quality Growth Through a Glocalized Model
Sisram has transitioned from global direct sales to a “glocalization” model, shifting its focus from rapid expansion to deeply rooted local operations. By combining global resources with local insights, the Company is building end-to-end value chain capabilities that drive sustainable, high-quality growth.

APAC remained a strong growth engine with a 17.6% revenue increase YoY, led by outstanding performances in Thailand and South Korea. In China, Sisram is accelerating the integration of R&D, manufacturing, and commercialization to create a local closed-loop ecosystem. This not only strengthens margins and supply chain resilience, but also transforms the direct sales business into a regional innovation hub.

With “global standards and local innovation” at its core, Sisram is reinforcing its position in strategic markets and unlocking new growth momentum worldwide.

Outlook
Looking ahead to H2 2025, Sisram forecasts a stronger performance both in revenue and net profit.

The Company will strategically focus on strengthening corporate leadership in APAC and North America, its key growth engines. Through regional innovation and wellness ecosystem synergy, Sisram will build differentiated competitive advantages while enhancing operational excellence and market share.

In North America, the Company will build on the successful launch of Universkin by Alma and Alma IQ, alongside continued strong demand for Sisram’s energy-based medical device solutions, advancing an innovative, integrated approach to aesthetic care.

In the APAC region, the Company will expedite the launch of its long-lasting botulinum toxin product DAXXIFY in mainland China, while driving the commercial expansion of core injectables such as Revanesse and Profhilo in key markets. Concurrently, it will advance the launch and market ramp-up of the “钛提升” and “普娜提” energy-based devices in China, reinforcing the competitive edge in premium aesthetic solutions.

By building a synergistic ecosystem of product portfolio, technological innovation, and market strategy, the Company aims to fuel high-quality, sustainable growth with forward-looking vision and strategic execution.

Mr. Liu Yi, Chairman and Executive Director of Sisram, commented: “Sisram is accelerating the development of an integrated growth model built on technology innovation, ecosystem expansion, and glocalization. The upcoming launch of DAXXIFY in mainland China will serve as a key milestone, working in synergy with our global injectables portfolio to establish a strong second growth engine. By combining AI integration with material innovations, we are expanding the frontiers of medical aesthetics, while strengthening supply chain resilience through localized end-to-end capabilities and a multi-center manufacturing network. Looking ahead, we remain committed to optimizing resources, unlocking ecosystem synergies, and building a more competitive, future-ready medical aesthetics platform.”

Mr. Lior Dayan, CEO of Sisram and Alma, said: “In the first half of 2025, Sisram advanced its position as a holistic wellness ecosystem leader in medical aesthetics. Leveraging AI-powered innovation and continuous technological advancement, we introduced major advancements. We also strengthened our intelligent infrastructure to deliver greater value for customers and elevate patient experience. Combined with accelerated commercialization, localized market strategies, and a reinforced supply chain, these capabilities have driven strong performance across our core markets. Our global presence enabled us to navigate regional challenges, invest confidently in growth initiatives, and lay a solid foundation for sustainable leadership in the years ahead.”

[1] The term “international market” refers to the global market excluding North America.

About Sisram Medical Ltd
Sisram Medical Ltd (1696.HK) is a global leader in medical aesthetic solutions with over 25 years of expertise in energy-based devices (EBD). Built on a legacy of innovation and clinical excellence, the Company’s synergistic ecosystem spans EBD technologies, injectables, diagnostics, and complementary solutions.

Sisram serves customers in over 110 countries and regions, delivering award-winning products that set new standards in safety, efficacy, and personalized aesthetic care for millions of patients worldwide.

The Company is majority-owned by Fosun Pharma, one of China’s leading healthcare groups, and was listed on the Main Board of the Hong Kong Stock Exchange in September 2017.

Sisram Medical – Enhancing Quality of Life
http://www.sisram-medical.com

H World Group Reports Robust Q2 Results, Driven by Asset-light Strategy

SINGAPORE and SHANGHAI, Aug. 20, 2025 /PRNewswire/ — H World Group Limited (NASDAQ: HTHT) (HK: 01179), one of the world’s leading hospitality groups, delivered robust second-quarter results for 2025, including a 22.8% year-on-year rise in asset-light revenues. Growth in hotel GMV, loyalty engagement, and network expansion further demonstrated the company’s robust momentum and effective execution of its strategy.

The latest version - Hanting Hotel 4.0 in Nanjing, Jiangsu Province
The latest version – Hanting Hotel 4.0 in Nanjing, Jiangsu Province

 

Continuous Asset-light Push Yields Strong Results

Hotel turnover[1] increased 15.0% year-over-year to RMB 26.9 billion in the second quarter of 2025. Total adjusted EBITDA rose 11.3% y-o-y to RMB 2.3 billion.

In line with its commitment to transparency and focus on an asset-light strategy, H World Group has, for the first time, separated results between its manachised and franchised hotels and its leased and owned hotels. Manachise and franchise gross operating profit reached RMB 1.9 billion in the second quarter of 2025, a 23.2% increase from the prior year. Manachise and franchise hotels accounted for 64% of total gross operating profit in that quarter, compared with 57% in the prior year.

Jin Hui, CEO of H World, says, “Supported by our asset-light strategy, we delivered robust operating profit growth in the second quarter, driven by network expansion, despite a modest year-over-year RevPAR decline. On the development front, we opened another 595 hotels in the quarter, well on track to achieve our 2,300 gross opening target for the full year of 2025.”

Expanding Scale, Loyalty, and Brand Leadership

H World Group, celebrating its 20th anniversary this year, operates a total of 12,137 hotels or 1,184,915 hotel rooms globally as of June 30.

One of the Group’s flagship brands, Hanting Hotel, was ranked No. 1 by HOTELS Magazine’s “World’s Top 50 Hotel Brands” list, with 4,401 hotels or 378,569 rooms in operation. Orange Hotel also reached a milestone, surpassing 1,000 hotels in operation.

The Group accelerated its presence in the upper-midscale market in Q2 2025, with more than 1,500 hotels in operation and pipeline across China. InterCity Hotel drove the segment’s performance, delivering a 57.1% year-on-year increase, reflecting strong demand for higher-end offerings. Alongside the achievements of Hanting and Orange, this underscores the appeal of the Group’s strong and diverse brand portfolio to guests and partners alike.

Customer loyalty and direct engagement continued to strengthen, with membership reaching 288 million as of June 30. Direct bookings through H World CRS accounted for 65.1% of total reservations, representing a 5.2 percentage point increase from the prior year, reflecting the effectiveness of the Group’s digital platforms.

Optimistic on Growth Momentum

As of June 30, H World had a total of 2,947 hotels in the development pipeline globally.

“We are positive on the long-term growth for China’s travel and hospitality industry. We will continue focusing on building our own core competencies, expanding our high-quality network, upgrading our supply chain, enhancing our brand positioning and ‘service excellence’, and strengthening our sales capabilities.” Jin Hui said.

For the first half of 2025, the Company’s Board of Directors has declared a cash dividend of approximately US$250 million, reflecting its continued commitment to delivering shareholder returns. The dividend amounts to US$0.081 per ordinary share, or US$0.81 per American Depositary Share (ADS).

For the full release please visit:
(https://ir.hworld.com/news-releases/news-release-details/h-world-group-limited-reports-second-quarter-and-interim-2025)

About H World Group Limited

Originated in China, H World Group Limited (NASDAQ:HTHT) (HK:01179) is a key player in the global hotel industry. H World’s brands include HanTing Hotel, JI Hotel, Crystal Orange Hotel, Steigenberger Hotels & Resorts, MAXX, Jaz in the City, IntercityHotel, Zleep Hotels and Steigenberger Icons. In addition, H World also has the rights as master franchisee for Mercure, Ibis and Ibis Styles, and co-development rights for Grand Mercure and Novotel, in the pan-China region.

For more information, please visit H World’s website: https://ir.hworld.com

H World undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, unless required by applicable law.

For media inquiry, please contact:

Lihuan Wang media@hworld.com
Zheming Xing zheming@taskforce-china.cn
Zhibin Lang  zhibin.lang@taskforce-china.cn

1Hotel turnover refers to total transaction value of room and non-room revenue from H World hotels (i.e., leased and operated, manachised and franchised hotels).

 

GIGABYTE Teams Up with CORSAIR Featuring Cableless STEALTH ICE PC Build and STEALTH Motherboard Giveaway at Gamescom

TAIPEI, Aug. 20, 2025 /PRNewswire/ — GIGABYTE, the world’s leading computer brand, teams up with CORSAIR at Gamescom to demonstrate the STEALTH ICE PC build with a reverse-connector motherboard. The collaboration aims to deliver the concept of cableless and pure-white aesthetics to gamers and creators. At the core of the partnership is the revolutionary STEALTH design, a concept first introduced by GIGABYTE in 2022, moving all connectors to the rear side for a neater outlook.

GIGABYTE Teams Up with Corsair Featuring Cableless STEALTH ICE PC Build and STEALTH Motherboard Giveaway at Gamescom
GIGABYTE Teams Up with Corsair Featuring Cableless STEALTH ICE PC Build and STEALTH Motherboard Giveaway at Gamescom

The centerpiece of the STEALTH build is the X870 AORUS STEALTH ICE motherboard, featuring reverse connectors for a faster, smoother, and cable-free assembly. This innovative design not only simplifies installation and maintenance but also frees up front-side space for custom cooling, RGB lighting, and personalized styling. With its pure-white aesthetic, the STEALTH ICE design caters perfectly to builders looking for a clean and aesthetic look.

GIGABYTE showcases the clean STEALTH build alongside other themed PCs at the CORSAIR booth – Hall 7.1, Booth #C-030. These builds are designed for creators and gamers who value exceptional performance paired with redefined aesthetic outlooks. Whether attending Gamescom in person or joining online, GIGABYTE invites all fans to participate in the Gamescom campaign starts from August 15th to 24th, including a find-the-chibi EAGLE EYE TEST on AORUS social media and visiting the CORSAIR booth to find the STEALTH code for a chance to win the X870 AORUS STEALTH ICE motherboard and FRAME 4000D chassis.

Whether you’re a PC enthusiast or a newbie, GIGABYTE welcomes everyone to explore the innovation of STEALTH design through the Gamescom campaign. Visit AORUS official Instagram for more information and experience the STEALTH innovation in person at the CORSAIR booth.

TGE alongside with AMTD Obtain Successful Court Decisions against Unauthorised and Infringing Activities in Austria

PARIS, NEW YORK and SINGAPORE, Aug. 20, 2025 /PRNewswire/ — AMTD Group Inc. (“AMTD”), alongside The Generation Essential Group (“TGE”; NYSE:TGE), a subsidiary of AMTD under AMTD Digital (NYSE:HKD), (“Group”) as the exclusive global owner of the global fashion publications under “L’OFFICIEL AMTD” and its associated brands, jointly announce further successes against IP infringers.

We have been pursuing legal action against unauthorised and infringing activities around the globe and achieving remarkable success to protect and uphold the brand values of “L’OFFICIEL AMTD”.

Most recently, there is an infringer in Austria called Regalia Company GmbH, which has been improperly using the “lofficielaustria” and “L’Officiel Austria” brands, and publishing a magazine “L’OFFICIEL Austria”.

We are very pleased to announce that on 29 July 2025, we successfully obtained an injunction from the Vienna Commercial Court in Austria against the abovementioned infringing activity (See decision in respect of case number 10 Cg 38/25f).  We will be enforcing the order obtained to the fullest extent in our relentless protection of the Group’s intellectual property.

Relatedly, we have also successfully obtained a decision from the Asian Domain Name Dispute Resolution Centre, Case No. HK-2502000, against Regalia Company GmbH and an individual associated with that company, Sergei Mikhailovich Gudakov, cancelling the domain name https://lofficielshop.com/, which has been illegitimately selling the “L’OFFICIEL Austria” publication. This decision notably found that the Respondents’ conduct “constitutes both a lack of legitimate right or interest and evidence of bad faith use”.

These decisions demonstrate the Group’s steadfast commitment to protecting its trademarks and brand reputation across all jurisdictions globally.

We have not endorsed nor have we partnered or allowed these persons to publish any Austrian edition and the decisions we have obtained demonstrate that continuous publication is clearly an infringement of our rights, and grossly illegitimate.

We wish to remind our loyal readers, brand holders and the public that as demonstrated by the legal decisions we have obtained, this current “L’OFFICIEL AUSTRIA” (with IG account as https://www.instagram.com/lofficielaustria?igsh=c3h2dWhzcmUxbGFs) is not in any way connected with the Group, the L’Officiel AMTD network and the brand’s heritage and global standing and we caution any dealings with this publication and persons.

About AMTD Group Inc.
AMTD Group is a conglomerate with a core business portfolio spanning across media and entertainment, education and training, and premium assets and hospitality sectors.

About AMTD IDEA Group
AMTD IDEA Group (NYSE: AMTD; SGX: HKB) represents a diversified institution and digital solutions group connecting companies and investors with global markets. Its comprehensive one-stop business services plus digital solutions platform addresses different clients’ diverse and inter-connected business needs and digital requirements across all phases of their life cycles. AMTD IDEA Group is uniquely positioned as an active super connector between clients, business partners, investee companies, and investors, connecting the East and the West. For more information, please visit www.amtdinc.com or follow us on X (formerly known as “Twitter”) at @AMTDGroup.

About AMTD Digital Inc.
AMTD Digital Inc. (NYSE: HKD) is a comprehensive digital solutions platform headquartered in France. Its one-stop digital solutions platform operates key business lines including digital media, content and marketing services, investments as well as hospitality and VIP services. For AMTD Digital’s announcements, please visit https://ir.amtdigital.net/investor-news.

About The Generation Essentials Group
The Generation Essentials Group (NYSE: TGE), jointly established by AMTD Group, AMTD IDEA Group (NYSE: AMTD; SGX: HKB) and AMTD Digital Inc. (NYSE: HKD), is headquartered in France and focuses on global strategies and developments in multi-media, entertainment, and cultural affairs worldwide as well as hospitality and VIP services. TGE comprises L’Officiel, The Art Newspaper, movie and entertainment projects. Collectively, TGE is a diversified portfolio of media and entertainment businesses, and a global portfolio of premium properties.

Safe Harbor Statement 
This press release contains statements that may constitute “forward-looking” statements pursuant to the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “aims,” “future,” “intends,” “plans,” “believes,” “estimates,” “likely to,” and similar statements. Statements that are not historical facts, including statements about the beliefs, plans, and expectations of AMTD IDEA Group and/or AMTD Digital, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. Further information regarding these and other risks is included in the filings of AMTD IDEA Group, AMTD Digital and The Generation Essentials Group with the SEC. All information provided in this press release is as of the date of this press release, and none of AMTD IDEA Group, AMTD Digital and The Generation Essentials Group undertakes any obligation to update any forward-looking statement, except as required under applicable law.

For more information, please contact:
For AMTD IDEA Group:
IR Office
AMTD IDEA Group
EMAIL: ir@amtdinc.com

For AMTD Digital Inc.:
IR Office
AMTD Digital Inc.
EMAIL: ir@amtdigital.net

For The Generation Essentials Group:
IR Office
The Generation Essentials Group
EMAIL: tge@amtd.world

Zylox-Tonbridge Announces 2025 Interim Results: Strong Revenue Growth with Net Profit Surging Over 76% Year-over-Year

HANGZHOU, China, Aug. 20, 2025 /PRNewswire/ — Zylox-Tonbridge Medical Technology Co., Ltd. (HKEX: 2190, hereinafter referred to as “Zylox-Tonbridge” or the “Company”) today announced its interim results for the six months ended June 30, 2025. The Company achieved robust revenue growth of 31.7% year-over-year (YoY) to RMB 482 million, while net profit surged by 76.0% to exceed RMB 121 million, representing a net profit margin of 25.1%.

In the first half of 2025, Zylox-Tonbridge maintained solid performance in its core neurovascular and peripheral vascular intervention businesses. Neurovascular product revenue reached RMB 304 million, up 25.0% YoY, while peripheral vascular product revenue climbed to RMB 176 million, a YoY increase of 46.2%. Driven by the Company’s continuous focus on lean operations, combined R&D, selling, and administrative expenses as a percentage of revenue declined by 7 percentage points compared to the same period last year, further strengthening the Company’s profitability profile.

The Company’s international business sustained strong growth in the first half of 2025, with revenue reaching RMB 15.72 million. By June 30, the Company had commercialized 22 products in 27 countries and regions, with over 31 products under registration in 23 markets. Its global network covers 52 countries and regions through partnerships with over 60 local distributors. With overseas commercialization accelerating and revenue contribution rising, the international business is becoming a new growth driver.

Mature Portfolio Delivers Growth as Innovative Products Poised for Launch

Leveraging a comprehensive and high-quality product portfolio and an efficient commercial team, Zylox-Tonbridge achieved strong sales growth in the first half of the year. Several VBP-selected products were successfully renewed under a more stable procurement environment, supporting continued market penetration and share gains.

Sales of multiple flagship products, including the SilverSnake® Intermediate Catheter Series, neurovascular guidewires, Kylin™ Flow Diverter, UltraFree® Drug-Coated PTA Balloon Catheter, and Zylox Octoplus® IVC Filter, recorded strong growth with increased market penetration. The Phoenix™ Coil System secured renewal in the Jiangsu provincial procurement program.

By the end of the period, Zylox-Tonbridge’s network covered over 3,000 hospitals, with its products used in more than 1 million procedures, delivering high-quality and affordable treatment to patients worldwide.

While advancing the commercialization of mature products, the Company remained focused on differentiated innovation to meet unmet clinical needs. In the first half, the ZYLOX Eagle® Aspiration System and the TONBRIDGE Shunfeng™ Balloon Vascular Closure Device received regulatory approval, further strengthening the product portfolio. In the second half, the Company also anticipates approvals for a large-lumen thrombus aspiration catheter, a self-expandable intracranial stent, and an OCT-guided peripheral atherectomy catheter series, enhancing treatment options in both peripheral and neurovascular interventions.

The Mammoth Peripheral Large Lumen Thrombus Aspiration Catheter is the only domestically developed 12F–18F aspiration device in China, with a unique trumpet design and high aspiration efficiency, offering a new solution for treating deep vein thrombosis. In the neurovascular segment, the Company is advancing a self-expanding aneurysm embolization device that combines the advantages of coils and flow diverter technologies, aiming to address the treatment challenge of wide-neck bifurcation aneurysms.

As of the announcement date, Zylox-Tonbridge had a pipeline of 73 products, 50 of which have been approved by the NMPA. The Company will continue to focus on differentiated innovation with real clinical value to provide more comprehensive solutions for patients.

Global Expansion Advances with Product Launches and Broader Market Coverage

In the first half of 2025, Zylox-Tonbridge increased investment in international R&D, regulatory registration, and commercialization, driving rapid global expansion. The Company’s products now cover seven of the world’s top 10 medical device markets, including France, Germany, and Italy, while also achieving strong growth in emerging markets such as Brazil, India, and South Africa — creating new momentum for its international business.

In emerging markets, the ZYLOX Unicorn™ Vascular Closure System received regulatory approval in Indonesia, marking the Company’s first product approved in Southeast Asia. The ZYLOX Phoenix™ Peripheral Fibered Detachable Coil Occlusion System was approved in Ecuador, further enriching the Company’s portfolio in South America. In Europe, the Company continues post market studies and actively participates in leading conferences such as LINC 2025 and LINNC PARIS 2025 to strengthen brand visibility. Supported by a track record of consistent and reliable product quality, the Company has also gained growing recognition from top overseas hospital groups, including Asklepios and SANA.

Zylox-Tonbridge remains committed to its mission of “Innovation for Quality Life.” The Company will continue to leverage its full-spectrum product portfolio and lean operations to strengthen its position in the China market and accelerate international growth. By focusing on differentiated innovation with real clinical value, Zylox-Tonbridge aims to achieve long-term sustainable growth and contribute to global healthcare innovation.